CENEGERMIN

Tracking # 20-849331

$99999.00

There are no ratings for this course

Learn more

Educator STATPEARLS PUBLISHING, LLC

CE Broker Reporting Reported automatically

Method Computer-Based Training

Course overview

CENEGERMIN IS A MEDICATION USED IN THE MANAGEMENT OF NEUROTROPHIC KERATITIS. IT IS IN THE RECOMBINANT HUMAN NERVE GROWTH FACTOR (RHNGF) CLASS OF MEDICATIONS. THIS ACTIVITY DESCRIBES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR CENEGERMIN AS A VALUABLE AGENT IN TREATING NEUROTROPHIC KERATITIS. IN ADDITION, THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF PATIENTS WITH NEUROTROPHIC KERATITIS.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I